Grants per year
Personal profile
Certifications and Licenses
Transplant Hepatology | |
Gastroenterology |
Training Experience
1999 | Residency, University of Chicago Hospitals |
2002 | Fellowship, Northwestern University, McGaw Medical Center (Northwestern Memorial Hospital) |
Education/Academic qualification
MD, University of Illinois at Chicago
… → 1996
Medicine, MD, University of Illinois at Chicago
… → 1996
Research interests
- Colonoscopy
- Esophagogastroduodenoscopy (EGD)
- Hepatitis
- Liver Biopsy
- Liver/Hepatic Disease
- Non-Alcoholic Fatty Liver Disease
- Variceal Banding
- Viral Hepatitis
Fingerprint
- 4 Similar Profiles
Network
Grants
-
Prot#EDP 305-102: A Phase 2b Randomized, Double Blind, Placebo-Controlled, Multicenter Study Evaluating Safety and Efficacy of EDP-305 in Subjects with Liver-Biopsy Proven Non-Alcoholic Steatohepatitis (NASH)”
ICON Clinical Research, LLC, Enanta Pharmaceuticals, Inc.
7/31/20 → 7/31/23
Project: Research project
-
Prot#VK2809-202: A Phase 2B, Randomized, Double-Blind, Placebo-Controlled, Multicenter Study to Assess the Efficacy, Safety, and Tolerability of VK2809 Administered for 52 Weeks Followed by a 4-Week Off-Drug Phase in Subjects with Biopsy Proven Non-Alcoh
Covance Inc., Viking Therapeutics, Inc.
3/4/20 → 3/4/23
Project: Research project
-
Prot# Aramchol-018: A Phase 3/4, Multinational, Multicenter, Double-Blind, Placebo-Controlled Clinical Study to Evaluate the Efficacy and Safety of Aramchol in Subjects with Nonalcoholic Steatohepatitis (NASH)
Covance Inc., Galmed Research and Development Ltd.
12/23/19 → 12/23/23
Project: Research project
-
Prot# MGL-3196-11: A Phase 3, Multinational, Double-Blind, Randomized, Placebo-Controlled Study of MGL-3196 (resmetirom) in Patients With Non-Alcoholic Steatohepatitis (NASH) and Fibrosis to Resolve NASH and Reduce Progression to Cirrhosis and/or Hepatic
Pharmaceutical Research Associates, Inc., Madrigal Pharmaceuticals, Inc.
12/20/19 → 12/20/22
Project: Research project
Research Output
-
Thanks to CLD for Small Favors: Reduced CVD Risk in Patients Awaiting Liver Transplantation
Shroff, H. & Rinella, M. E., Jan 2021, In: Digestive diseases and sciences. 66, 1, p. 7-9 3 p.Research output: Contribution to journal › Editorial › peer-review
Open Access -
A randomized, double-blind, multicenter, phase 2b study to evaluate the safety and efficacy of a combination of tropifexor and cenicriviroc in patients with nonalcoholic steatohepatitis and liver fibrosis: Study design of the TANDEM trial
Pedrosa, M., Seyedkazemi, S., Francque, S., Sanyal, A., Rinella, M., Charlton, M., Loomba, R., Ratziu, V., Kochuparampil, J., Fischer, L., Vaidyanathan, S. & Anstee, Q. M., Jan 2020, In: Contemporary Clinical Trials. 88, 105889.Research output: Contribution to journal › Article › peer-review
Open Access18 Scopus citations -
Cilofexor, a Nonsteroidal FXR Agonist, in Patients With Noncirrhotic NASH: A Phase 2 Randomized Controlled Trial
Patel, K., Harrison, S. A., Elkhashab, M., Trotter, J. F., Herring, R., Rojter, S. E., Kayali, Z., Wong, V. W. S., Greenbloom, S., Jayakumar, S., Shiffman, M. L., Freilich, B., Lawitz, E. J., Gane, E. J., Harting, E., Xu, J., Billin, A. N., Chung, C., Djedjos, C. S., Subramanian, G. M. & 4 others, , Jul 1 2020, In: Hepatology. 72, 1, p. 58-71 14 p.Research output: Contribution to journal › Article › peer-review
25 Scopus citations -
Clinical assessment for high-risk patients with non-alcoholic fatty liver disease in primary care and diabetology practices
Younossi, Z. M., Corey, K. E., Alkhouri, N., Noureddin, M., Jacobson, I., Lam, B., Clement, S., Basu, R., Gordon, S., Ravendhra, N., Puri, P., Rinella, M., Scudera, P., Singal, A. K. & Henry, L., Aug 1 2020, In: Alimentary Pharmacology and Therapeutics. 52, 3, p. 513-526 14 p.Research output: Contribution to journal › Article › peer-review
4 Scopus citations -
Effects of Belapectin, an Inhibitor of Galectin-3, in Patients With Nonalcoholic Steatohepatitis With Cirrhosis and Portal Hypertension
The Belapectin (GR-MD-02) Study Investigators, Apr 2020, In: Gastroenterology. 158, 5, p. 1334-1345.e5Research output: Contribution to journal › Article › peer-review
Open Access30 Scopus citations